{"total":13,"page":1,"pageSize":25,"pages":1,"millis":0,"query":{"q":"","state":"","metro":"","industry":"","agency":"","kind":"context","level":"","type":"","quarter":"2021Q1","grade":"","collection":"AGY-FED-HEALTH-OTHER","from":"","to":"","sort":"relevance"},"items":[{"id":"AGY-FED-HEALTH-OTHER-086","kind":"context","level":"federal","jurisdiction":"United States (federal); Social Security Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Social Security Administration (Andrew Saul, Commissioner; press release by Mark Hinkle, Acting Press Officer)","instrument":"Press release of Mar. 16, 2020: \u0027Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service\u0027","title":"Effective March 17, 2020, Social Security Offices Will Only Offer Phone Service ** Online Services Remain Available **","dateIssued":"2020-03-16","startDate":"2020-03-17","endDate":"2022-04-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["CRT","CLOSE","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-086","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-086"},{"id":"AGY-FED-HEALTH-OTHER-027","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA","instrument":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","title":"COVID-19 Public Health Emergency Response and 42 CFR Part 2 Guidance","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-027","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-027"},{"id":"AGY-FED-HEALTH-OTHER-041","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 19, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-19","startDate":"2020-03-19","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-041","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-041"},{"id":"AGY-FED-HEALTH-OTHER-067","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Veterans Affairs, Veterans Benefits Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Department of Veterans Affairs, Veterans Benefits Administration","instrument":"VA announcement of Mar. 31, 2020: VBA closed its 56 regional offices to the public Mar. 19, 2020; benefit briefings on military installations discontinued Mar. 30, 2020; services shifted to telephone and virtual channels","title":"VA expands virtual services to support Veterans amid regional office closures due to COVID-19 pandemic","dateIssued":"2020-03-31","startDate":"2020-03-19","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["CRT","TELE"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-067","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-067"},{"id":"AGY-FED-HEALTH-OTHER-043","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance for Industry and FDA Staff: Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (March 2020)","title":"Enforcement Policy for Ventilators and Accessories and Other Respiratory Devices During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency","dateIssued":"2020-03-22","startDate":"2020-03-22","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-043","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-043"},{"id":"AGY-FED-HEALTH-OTHER-042","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Drug Evaluation and Research","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDER","instrument":"Guidance for Industry: Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19) (Mar. 24, 2020; updated Mar. 27 and Apr. 15, 2020, and later)","title":"Temporary Policy for Manufacture of Alcohol for Incorporation Into Alcohol-Based Hand Sanitizer Products During the Public Health Emergency (COVID-19)","dateIssued":"2020-03-24","startDate":"2020-03-24","endDate":"2021-12-31","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-042","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-042"},{"id":"AGY-FED-HEALTH-OTHER-044","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Devices and Radiological Health","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CDRH","instrument":"Guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Mar. 25, 2020; revised Apr. 2020, May 2020, Sept. 2021; superseded Sept. 5, 2023)","title":"Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency","dateIssued":"2020-03-25","startDate":"2020-03-25","endDate":"2023-09-05","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","MASK","OTHER"],"grade":"secondary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-044","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-044"},{"id":"AGY-FED-HEALTH-OTHER-045","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency (Mar. 26, 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency","dateIssued":"2020-03-26","startDate":"2020-03-26","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-045","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-045"},{"id":"AGY-FED-HEALTH-OTHER-028","kind":"context","level":"federal","jurisdiction":"United States (federal); Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment","instrument":"OTP Guidance for Patients Quarantined at Home with the Coronavirus (doorstep delivery protocol) (updated Mar. 30, 2020)","title":"OTP Guidance for Patients Quarantined at Home with the Coronavirus","dateIssued":"2020-03-30","startDate":"2020-03-30","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","QUAR","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-028","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-028"},{"id":"AGY-FED-HEALTH-OTHER-046","kind":"context","level":"federal","jurisdiction":"United States (federal); Food and Drug Administration, Center for Food Safety and Applied Nutrition","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Food and Drug Administration, CFSAN","instrument":"Guidance for Industry: Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency (Apr. 2020)","title":"Temporary Policy Regarding Nutrition Labeling of Standard Menu Items in Chain Restaurants and Similar Retail Food Establishments During the COVID-19 Public Health Emergency","dateIssued":"2020-04-01","startDate":"2020-04-01","endDate":"2023-11-07","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-046","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-046"},{"id":"AGY-FED-HEALTH-OTHER-025","kind":"context","level":"federal","jurisdiction":"United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies","instrument":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","title":"FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency","dateIssued":"2020-04-21","startDate":"2020-04-21","endDate":"2021-11-18","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-025","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-025"},{"id":"AGY-FED-HEALTH-OTHER-021","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA213)","instrument":"DEA-DC-043 (EO-DEA213), guidance: Administering certain controlled substances in the parking lot of a health care provider\u0027s DEA-registered location during the COVID-19 public health emergency","title":"Administering Certain CS in the parking lot of a healthcare provider\u0027s DEA-registered location during the COVID-19 public health emergency","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"2021-09-30","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-021","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-021"},{"id":"AGY-FED-HEALTH-OTHER-022","kind":"context","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","collection":"AGY-FED-HEALTH-OTHER","issuer":"Drug Enforcement Administration, Diversion Control Division (guidance document EO-DEA192)","instrument":"DEA-DC-044 (EO-DEA192), guidance: Telemedicine and separate State registration","title":"Telemedicine: Will I need to hold a separate DEA registration in the state where my patients are located?","dateIssued":"2020-07-28","startDate":"2020-07-28","endDate":"","quarters":["2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["HC","TELE","OTHER"],"grade":"primary","fileExists":true,"url":"/library/AGY-FED-HEALTH-OTHER-022","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-022"}],"facets":{"kind":[{"value":"context","label":"Context (guidance or announcement)","count":13}],"level":[{"value":"federal","label":"Federal","count":13}],"state":[],"type":[{"value":"OTHER","label":"Other","count":11},{"value":"HC","label":"Health care orders","count":6},{"value":"SUPPLY","label":"Supply chain","count":5},{"value":"TELE","label":"Telework mandate","count":3},{"value":"CRT","label":"Courts and public offices","count":2},{"value":"CLOSE","label":"Business closure","count":1},{"value":"MASK","label":"Face-covering requirement","count":1},{"value":"QUAR","label":"Quarantine and isolation","count":1}],"quarter":[{"value":"2020Q3","label":"2020 Q3","count":13},{"value":"2020Q4","label":"2020 Q4","count":13},{"value":"2021Q1","label":"2021 Q1","count":13},{"value":"2021Q2","label":"2021 Q2","count":13},{"value":"2021Q3","label":"2021 Q3","count":13},{"value":"2020Q2","label":"2020 Q2","count":11}],"grade":[{"value":"primary","label":"Primary source read","count":12},{"value":"secondary","label":"Confirmed from a secondary source","count":1}],"industry":[],"agency":[{"value":"FED-HEALTH-OTHER","label":"Other federal health agencies","count":13}]}}